Lyell Immunopharma Inc. (LYEL)
NASDAQ: LYEL
· Real-Time Price · USD
10.07
0.33 (3.39%)
At close: Jun 16, 2025, 3:59 PM
10.17
0.94%
After-hours: Jun 16, 2025, 04:04 PM EDT
3.39% (1D)
| Bid | 9.67 |
| Market Cap | 149.19M |
| Revenue (ttm) | 65K |
| Net Income (ttm) | -334.52M |
| EPS (ttm) | -25 |
| PE Ratio (ttm) | -0.4 |
| Forward PE | -0.66 |
| Analyst | Hold |
| Ask | 10.41 |
| Volume | 107,256 |
| Avg. Volume (20D) | 99,503 |
| Open | 9.83 |
| Previous Close | 9.74 |
| Day's Range | 9.21 - 10.35 |
| 52-Week Range | 7.65 - 47.00 |
| Beta | -0.27 |
About LYEL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LYEL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LYEL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+19.35%
Lyell Immunopharma shares are trading higher. The ...
Unlock content with
Pro Subscription
7 months ago
-5.22%
Lyell Immunopharma shares are trading higher after the company announced it will acquire privately-owned clinical-stage biotechnology company ImmPACT Bio.
